Lazard, Inc. SEC Filings

Lazard, Inc. executive Christopher Hogbin, CEO of Asset Management, acquired 2,716 Restricted Stock Units (RSUs) at no cost through dividend equivalent reinvestment tied to existing RSU awards. Each RSU represents one share of common stock. After this grant, he holds 263,705 RSUs, excluding 11,829 common shares separately beneficially owned. Portions of the new RSUs are scheduled to vest in three tranches through 2029.

Lazard, Inc. Chief Operating Officer Alexandra Soto received an award of 3,138 Restricted Stock Units (RSUs) on Common Stock. The filing classifies this as a grant or award acquisition, not an open-market purchase or sale, and each RSU represents a contingent right to one share of Common Stock.

The RSUs were acquired under dividend equivalent reinvestment provisions tied to existing RSU awards. Following this grant, Soto holds 304,621 RSUs directly, while a separate 148,185 shares of Common Stock are noted as directly or indirectly beneficially owned and are not part of this RSU award.

Of the newly reported RSUs, 1,000 are scheduled to vest on or around March 1, 2027, 1,079 on or around March 1, 2028, and 1,059 on or around March 1, 2029, providing a multi-year, stock-based compensation schedule.

Lazard, Inc. reported results from its Annual Meeting of Shareholders. Investors approved an amendment to the Certificate of Incorporation to declassify the board over a three-year period, moving the company toward annual director elections. After this approval, Lazard filed the amendment in Delaware, making it effective and simultaneously putting new Amended and Restated By-Laws into effect to reflect the phased declassification and clarify terms for directors filling new seats or vacancies.

Shareholders also backed a non-binding advisory vote on executive compensation, approved changes to the 2018 Incentive Compensation Plan, and ratified Deloitte & Touche LLP as independent auditor for 2026. These actions collectively update Lazard’s governance framework while maintaining existing audit oversight.

Lazard, Inc. director Andrew M. Alper received 857 Deferred Stock Units (DSUs) as a compensation grant. These DSUs were awarded on May 15, 2026 at a stated price of $0.00 per unit and increase his directly held DSU balance to 99,706 units. Under his annual election, these DSUs are received in lieu of cash fees and will convert into an equal number of Lazard common shares on a one-for-one basis after he leaves the board.

Lazard, Inc. director Stephen R. Howe Jr. received a grant of 100 Deferred Stock Units as part of his non-executive director compensation. These units were elected in lieu of cash under Lazard’s 2018 Incentive Compensation Plan and convert into common stock on a one-for-one basis after he leaves the Board.

Following this grant, Howe holds 10,498 Deferred Stock Units directly. The transaction is a routine equity-based compensation award rather than an open-market purchase or sale.

T. Rowe Price Associates, Inc. amended its Schedule 13G to report beneficial ownership of 9,601,861 shares of Lazard Inc common stock, representing 8.6% of the class. The filing lists 9,547,474 shares as sole voting power. The filing includes the statement that "beneficial ownership is expressly denied."

Ariel Investments, LLC reports beneficial ownership of 5,826,289 shares of Lazard Inc Common Stock, representing 5.2% of the class as of 03/31/2026. The filing states Ariel has sole voting power over 5,265,803 shares and sole dispositive power over 5,826,289 shares. The Schedule 13G notes these holdings are held on behalf of adviser clients; no single client holds an economic interest exceeding 5% of the class. The form is signed by James Prescott, Vice President, Compliance, dated 05/14/2026.

Lazard, Inc. reported stronger results for the three months ended March 31, 2026. Total revenue rose to $779,399 thousand from $669,164 thousand, driven by higher asset management fees and other revenue, while investment banking and advisory fees were roughly stable.

Net income attributable to Lazard increased to $100,916 thousand from $60,375 thousand, with diluted earnings per share rising to $0.91 from $0.56. Results included a $77,990 thousand pre-tax gain from the sale and deconsolidation of the Edgewater management vehicles. Lazard ended the quarter with $1,234,463 thousand in cash, cash equivalents and restricted cash and $1,700,000 thousand of senior notes outstanding. The company repurchased 41,502 shares in the quarter and had $107,295 thousand remaining under its share repurchase authorization.

Lazard, Inc. has entered into a Sale and Purchase Agreement to acquire 100% of Campbell Lutyens Holdings Limited, a global private capital advisory firm focused on fund placement, secondary advisory and GP capital advisory services. The aggregate consideration includes an initial closing payment of $460 million, a deferred payment of $115 million on the second anniversary of closing, and an earn-out of up to $85 million tied to revenue-growth targets through 2030.

The initial consideration is expected to be paid primarily in Lazard common stock using a $46.50 reference price, with cash used for closing adjustments. Deferred and earn-out amounts may be paid in stock, loan notes or cash, subject to a cap that limits total shares issued under the agreement to no more than 19.99% of Lazard’s voting power or outstanding shares at closing, with any excess settled in cash or loan notes. Some stock consideration will be subject to lock-up restrictions over roughly three years, and certain recipients face forfeiture and clawback terms.

The acquisition is subject to regulatory approvals, including conditions related to the U.K. Competition and Markets Authority, and may be terminated if not closed by March 31, 2027; in specified circumstances Lazard would owe a $50 million termination fee. Lazard expects the combined private capital advisory business, branded Lazard CL, to generate about $500 million in 2027 revenue and to be accretive to 2027 earnings and beyond.